Keyphrases
Type 1 Diabetic Patient
100%
Diabetic Nephropathy
100%
Losartan
100%
Renoprotective Effect
100%
Angiotensin Receptor Blockade
100%
Enalapril
75%
Angiotensin-converting Enzyme Inhibitor (ACEi)
75%
Albuminuria
62%
Mean Arterial Pressure
37%
Angiotensin II (Ang II)
37%
Blood Pressure
25%
Glomerular Filtration Rate
25%
A1 Receptor
25%
Renin-angiotensin System
25%
Bradykinin
25%
No Significant Difference
12%
Receptor Antagonist
12%
Placebo
12%
Randomized Double-blind
12%
Kidney Function
12%
Sodium Intake
12%
Hemoglobin A1c (HbA1c)
12%
Proteinuria
12%
New Drugs
12%
Pressure Function
12%
Hypertension Management
12%
Renal Effects
12%
Hemodynamic Effects
12%
Serum Potassium
12%
Specific Interventions
12%
Pharmacology, Toxicology and Pharmaceutical Science
Diabetes Mellitus
100%
Angiotensin Receptor
100%
Diabetic Nephropathy
100%
Losartan
100%
Angiotensin I
75%
Enalapril
75%
Albuminuria
62%
Dipeptidyl Carboxypeptidase
62%
Enzyme Inhibition
62%
Angiotensin II
37%
Scanning Electron Microscopy
25%
Bradykinin
25%
Receptor Antagonist
12%
Placebo
12%
Dipeptidyl Carboxypeptidase Inhibitor
12%
Receptor
12%
Isotopes of Potassium
12%
Renin
12%
Angiotensin
12%
Proteinuria
12%